Insider Buying: Ansell Limited (ASX:ANN) Insider Purchases 426 Shares of Stock

Ansell Limited (ASX:ANN) insider Debra (Debbie) Goodin acquired 426 shares of the stock in a transaction on Wednesday, February 26th. The shares were bought at an average price of A$35.10 ($22.21) per share, for a total transaction of A$14,952.17 ($9,463.40).

Debra (Debbie) Goodin also recently made the following trade(s):

• On Friday, February 21st, Debra (Debbie) Goodin acquired 1,427 shares of Ansell stock. The shares were bought at an average price of A$35.50 ($22.47) per share, for a total transaction of A$50,658.50 ($32,062.34).

Ansell Stock Performance

The company has a quick ratio of 1.13, a current ratio of 3.84 and a debt-to-equity ratio of 45.24. The company has a market capitalization of $3.33 billion, a P/E ratio of 39.82, a price-to-earnings-growth ratio of -14.40 and a beta of 0.46.

Ansell Increases Dividend

The business also recently disclosed a Interim dividend, which was paid on Wednesday, March 5th. Shareholders of record on Wednesday, March 5th were paid a dividend of $0.353 per share. This represents a yield of 0.95%. The ex-dividend date was Thursday, February 13th. This is a positive change from Ansell’s previous Interim dividend of $0.25. Ansell’s dividend payout ratio (DPR) is 67.06%.

About Ansell

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies.